Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial.
Solaymani-Dodaran M, Basiri P, Moradi M, Gohari K, Sheidaei A, Ahi M, Ghafoori Naeeni F, Ansarifar A, Rahimi Z, Gholami F, Karimi Rahjerdi A, Hamidi Farahani R, Naderi Saffar K, Ghasemi S, Shooshtari A, Honari M, Mozafari A, Khodaverdloo S, Forooghizadeh M.
Solaymani-Dodaran M, et al. Among authors: mozafari a.
Virol J. 2023 Jul 18;20(1):154. doi: 10.1186/s12985-023-02121-z.
Virol J. 2023.
PMID: 37464440
Free PMC article.
Clinical Trial.